Table 1.
LD-TMAc targeted residues on bCAII
| Probe | Label Site | Modification % | SASA % |
|---|---|---|---|
|
| |||
| 1† | His3 | 95 ± 4 | 81 |
| His63 | 50 ± 20 | 17.3 | |
|
|
|||
| 2† | His3 | 70 ± 20 | 81 |
| His63 | 60 ± 30 | 17.3 | |
| Ser181# | 0.3 ± 0.2 | 30 | |
| Ser171/Thr172 | 0.09 ± 0.08 | 31.5$ | |
| Lys166* | 0.06 ± 0.07 | 29.3 | |
|
|
|||
| 3‡ | His3 | 80 ± 30 | 81 |
| His63 | 70 ± 10 | 17.3 | |
| Ser72# | 30 ± 1 | 74.8 | |
| His2* | 2 ± 2 | 11.3 | |
| Ser28* | 1 ± 0.5 | 0 | |
| Ser64* | 0.5 ± 0.4 | 0.2 | |
| Ser171/Thr172 | 0.3 ± 0.1 | 31.5$ | |
| Lys250 | 0.2 ± 0.03 | 29.2 | |
| Lys44 | 0.1 ± 0.04 | 66.3 | |
Based on 6 replicates.
Based on 3 replicates.
Ser171 and Thr172 average.
An outlier replicate removed at at 95% confidence.
Statistically significant at 90% confidence. The rest of the data is statistically significant at 95% confidence.